Open on a desktop browser to explore the interactive map. The knowledge graph needs a larger screen and a pointer. On this device you are limited to the text below.
Dr. Ronald Roth Acu-Cell AI

Targeted Treatments for HER2-Positive Breast Cancer

Trastuzumab (Herceptin): A monoclonal antibody that specifically targets the HER2 receptor* on the surface of cancer cells to block growth signals.

Pertuzumab (Perjeta): Another monoclonal antibody often used in combination with trastuzumab* and chemotherapy to block HER2 dimerization.

Ado-Trastuzumab Emtansine (Kadcyla*): An antibody-drug conjugate that delivers a potent chemotherapy drug directly inside HER2-positive cancer cells.

Lapatinib (Tykerb): A tyrosine kinase inhibitor that blocks internal signaling pathways associated with both HER2 and EGFR* receptors.

AI-generated in the approach of Dr. Ronald Roth. Not his own words.
Traversing graph…
Connections

HER2-positive breast cancer - connections

-> HER2-positive breast cancer

Symptomatic drug therapy - connections

Symptomatic drug therapy ->

Breast cancer - connections

Breast cancer ->

-> Breast cancer

Overview
Loading graph...
Display TOP 100%
Loading full knowledge graph…
Building graph…
Preparing…
Filter by Relationship
Filter by Type
Some information may be incomplete, disputed, or incorrect. Review the supporting sources.